Dr. Lon D. Lynn

Family Medicine
LYNN Family Practice
3910 Northdale Blvd Ste 206, 
Tampa, FL 
Accepting New Patients
LYNN Family Practice
3910 Northdale Blvd Ste 206, 
Tampa, FL 

Overview

Lon Lynn is a primary care provider, practicing in Family Medicine in Tampa, Florida.

His clinical expertise encompasses Diabetic Neuropathy, Peripheral Neuropathy, Infant Hyperglycemia, and Cramp-Fasciculation Syndrome.

He is actively involved in clinical research, participating in 10 clinical trials. Dr. Lynn is currently accepting new patients.

Specialties

Family Medicine

Licenses

Family Medicine in FL

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D

Locations

LYNN Family Practice
3910 Northdale Blvd Ste 206, Tampa, FL 33624

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

An Interventional, Phase III, Double-blind, Randomized, Controlled, Parallel-group, Multi-site, Clinical Trial Evaluating the Efficacy and Safety of Qutenza® in Subjects With Post-surgical Neuropathic Pain
An Interventional, Phase III, Double-blind, Randomized, Controlled, Parallel-group, Multi-site, Clinical Trial Evaluating the Efficacy and Safety of Qutenza® in Subjects With Post-surgical Neuropathic Pain
Enrollment Status: Completed
Publish Date: April 17, 2026
Intervention Type: Drug
Study Drugs: Qutenza (Capsaicin) 8% Topical System, Capsaicin 0.04% Topical System
Study Phase: Phase 3
A Study of Donanemab Versus Placebo in Participants at Risk for Cognitive and Functional Decline of Alzheimer's Disease
A Study of Donanemab Versus Placebo in Participants at Risk for Cognitive and Functional Decline of Alzheimer's Disease
Enrollment Status: Active_not_recruiting
Publish Date: January 21, 2026
Intervention Type: Drug
Study Drug: Donanemab
Study Phase: Phase 3
A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Participants With Painful Diabetic Peripheral Neuropathy
A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Participants With Painful Diabetic Peripheral Neuropathy
Enrollment Status: Completed
Publish Date: October 09, 2025
Intervention Type: Other, Biological
Study Phase: Phase 3
Long-term, Prospective, Non-interventional, Extension of a Phase III, Randomized, Placebo-controlled, Multicenter Study to Assess the Safety & Efficacy of Engensis (VM202) in Subjects With Painful Diabetic Peripheral Neuropathy
Long-term, Prospective, Non-interventional, Extension of a Phase III, Randomized, Placebo-controlled, Multicenter Study to Assess the Safety & Efficacy of Engensis (VM202) in Subjects With Painful Diabetic Peripheral Neuropathy
Enrollment Status: Completed
Publish Date: October 09, 2025
Intervention Type: Drug, Genetic
Study Phase: Phase 3
An Adaptive, Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of Engensis in Participants With Painful Diabetic Peripheral Neuropathy
An Adaptive, Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of Engensis in Participants With Painful Diabetic Peripheral Neuropathy
Enrollment Status: Completed
Publish Date: October 09, 2025
Intervention Type: Biological, Other
Study Drug: Engensis
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Two-Arm, Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of LY3361237 as a Treatment for Adults With At Least Moderately Active Systemic Lupus Erythematosus
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Two-Arm, Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of LY3361237 as a Treatment for Adults With At Least Moderately Active Systemic Lupus Erythematosus
Enrollment Status: Terminated
Publish Date: January 20, 2025
Intervention Type: Drug
Study Drug: LY3361237
Study Phase: Phase 2
Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo After an Intensive Lifestyle Program in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight-Related Comorbidities: A Randomized, Double Blind, Placebo-Controlled Trial (SURMOUNT-3)
Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo After an Intensive Lifestyle Program in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight-Related Comorbidities: A Randomized, Double Blind, Placebo-Controlled Trial (SURMOUNT-3)
Enrollment Status: Completed
Publish Date: May 16, 2024
Intervention Type: Other, Drug
Study Drug: Tirzepatide
Study Phase: Phase 3
A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks (With a 48-week Safety Subset) in Subjects With Moderate to Severe COPD
A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks (With a 48-week Safety Subset) in Subjects With Moderate to Severe COPD
Enrollment Status: Completed
Publish Date: November 13, 2023
Intervention Type: Drug
Study Drug: Ensifentrine
Study Phase: Phase 3
A Double-blind, Randomized, Phase 2 Study to Investigate the Efficacy, Tolerability and Pharmacokinetics of MYMD1 in the Treatment of Participants Aged 65 Years or Older With Chronic Inflammation Associated With Sarcopenia/Frailty
A Double-blind, Randomized, Phase 2 Study to Investigate the Efficacy, Tolerability and Pharmacokinetics of MYMD1 in the Treatment of Participants Aged 65 Years or Older With Chronic Inflammation Associated With Sarcopenia/Frailty
Enrollment Status: Completed
Publish Date: October 30, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Enrollment Status: Completed
Publish Date: October 16, 2023
Intervention Type: Drug
Study Drug: Ensifentrine
Study Phase: Phase 3
View 9 Less Clinical Trials
Similar Doctors
Expertise in
105
conditions
Dr. Timothy S. Bailey
Family Medicine
Expertise in
105
conditions
Dr. Timothy S. Bailey
Family Medicine
Before you request

Bailey Family Care, Inc

1839 Health Care Dr New, 
Port Richey, FL 
 (10.2 miles away)
727-312-4445
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Timothy Bailey is a primary care provider, practicing in Family Medicine in Port Richey, Florida. Dr. Bailey is highly rated in 105 conditions, according to our data. His clinical expertise encompasses Low Blood Sugar, Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), and Maturity Onset Diabetes of the Young. Dr. Bailey is board certified in American Osteopathic Board Family Medicine/OMT. Dr. Bailey is currently accepting new patients.

Expertise in
86
conditions
Dr. Vincent J. Dilella
Family Medicine
Expertise in
86
conditions
Dr. Vincent J. Dilella
Family Medicine
Before you request

V.J. Dilella D.O. LLC

703 Virginia St, 
Dunedin, FL 
 (16.1 miles away)
727-734-4000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Vincent Dilella is a primary care provider, practicing in Family Medicine in Dunedin, Florida. Dr. Dilella is highly rated in 86 conditions, according to our data. His clinical expertise encompasses Anemia, Dementia, Urinary Tract Infection in Children, and N-Acetylglutamate Synthase Deficiency. Dr. Dilella is currently accepting new patients.

Expertise in
67
conditions
Dr. Eduardo P. Palanca
Family Medicine | General Practice | Internal Medicine
Expertise in
67
conditions
Dr. Eduardo P. Palanca
Family Medicine | General Practice | Internal Medicine
Before you request

Ronald C. Fernandez MD PA

2901 Rigsby Ln, 
Safety Harbor, FL 
 (11.0 miles away)
727-724-8777
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Eduardo Palanca is a primary care provider, practicing in Family Medicine and Internal Medicine in Safety Harbor, Florida. Dr. Palanca is highly rated in 67 conditions, according to our data. His clinical expertise encompasses Necrosis, Sepsis, Urinary Tract Infection in Children, Gastrostomy, and Hip Replacement. Dr. Palanca is currently accepting new patients.

Frequently Asked Questions about Dr. Lon D. Lynn

How do I make an appointment with Dr. Lon D. Lynn?

You can book an appointment with Dr. Lon D. Lynn by calling their office at 813-264-7922. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Lon D. Lynn a top-rated expert for Diabetic Neuropathy?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Lon D. Lynn is classified as an Experienced expert for Diabetic Neuropathy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Lon D. Lynn specialize in?

While Dr. Lon D. Lynn is a Family Medicine, they have specific expertise in Diabetic Neuropathy, Peripheral Neuropathy, and Infant Hyperglycemia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Family Medicine.

Does Dr. Lon D. Lynn accept my insurance?

Dr. Lon D. Lynn accepts most major insurance plans, including Aetna and Humana. We recommend calling the office directly at 813-264-7922 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Lynn's expertise for a condition
ConditionClose
        View All 11 Experienced Conditions
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile